NeuroMetrix, Inc. (NURO) to Exhibit at American Diabetes Association’s 73rd Scientific Sessions
6/11/2013 6:42:24 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it will exhibit and participate in the American Diabetes Association’s (ADA) 73rd Scientific Sessions. The ADA Scientific Sessions will be held on June 22-24 in Chicago at the McCormick Place Convention Center.
Help employers find you! Check out all the jobs and post your resume.